These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24022664)

  • 1. The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma.
    Liu K; Luo Y; Tian H; Yu KZ; He JX; Shen WY
    Tumour Biol; 2014 Feb; 35(2):995-1002. PubMed ID: 24022664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of liquid chromatography mass spectrometry analyses to identify LKB1-APC interaction in modulating Wnt/β-catenin pathway of lung cancer cells.
    Jian SF; Hsiao CC; Chen SY; Weng CC; Kuo TL; Wu DC; Hung WC; Cheng KH
    Mol Cancer Res; 2014 Apr; 12(4):622-35. PubMed ID: 24448687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of LKB1 suppresses Stat3 activity to promote the proliferation of esophageal carcinoma cells.
    Wang YQ; Dai WM; Chu XY; Yang B; Zhao M; Sun Y
    Mol Med Rep; 2014 Jun; 9(6):2400-4. PubMed ID: 24676538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway.
    Zang B; Huang G; Wang X; Zheng S
    Int J Clin Exp Pathol; 2015; 8(10):13687-94. PubMed ID: 26722596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma.
    Wang J; Zhang K; Wang J; Wu X; Liu X; Li B; Zhu Y; Yu Y; Cheng Q; Hu Z; Guo C; Hu S; Mu B; Tsai CH; Li J; Smith L; Yang L; Liu Q; Chu P; Chang V; Zhang B; Wu M; Jiang X; Yen Y
    Oncotarget; 2015 Aug; 6(22):18905-20. PubMed ID: 26056085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
    Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
    Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of PDRG1 Could Inhibit the Wnt Signaling Pathway in Esophageal Cancer Cells.
    Tao Z; Zhang Y; Zhu S; Ni Z; You Q; Sun X; Xu D
    Ann Clin Lab Sci; 2019 Nov; 49(6):794-803. PubMed ID: 31882431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
    Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
    J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
    Yang S; Li X; Shen W; Hu H; Li C; Han G
    J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β-Catenin and NF-κB signaling pathway.
    Zhou Y; Xu L; Wang J; Ge B; Wang Q; Wang T; Liu C; Wei B; Wang Q; Gao Y
    Cancer Sci; 2022 Oct; 113(10):3566-3578. PubMed ID: 35879265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence.
    Götzel K; Chemnitzer O; Maurer L; Dietrich A; Eichfeld U; Lyros O; Moulla Y; Niebisch S; Mehdorn M; Jansen-Winkeln B; Vieth M; Hoffmeister A; Gockel I; Thieme R
    BMC Gastroenterol; 2019 Mar; 19(1):38. PubMed ID: 30841855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/β-catenin signaling pathway and thioredoxin-interacting protein (TXNIP) mediate the "glucose sensor" mechanism in metastatic breast cancer-derived cells MDA-MB-231.
    Vaira S; Friday E; Scott K; Conrad S; Turturro F
    J Cell Physiol; 2012 Feb; 227(2):578-86. PubMed ID: 21448924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
    Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
    J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3β and sFRP1 in human pancreatic carcinoma.
    Yang HW; Liu GH; Liu YQ; Zhao HC; Yang Z; Zhao CL; Zhang XF; Ye H
    Biomed Pharmacother; 2016 Oct; 83():593-601. PubMed ID: 27459115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAB11A mediates the proliferation and motility of esophageal cancer cells via WNT signaling pathway.
    Zhao D; Wang B; Chen H
    Acta Biochim Pol; 2020 Dec; 67(4):531-538. PubMed ID: 33326197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
    Zhang LN; Zhao L; Yan XL; Huang YH
    J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.
    Lin-Marq N; Borel C; Antonarakis SE
    Mol Genet Genomics; 2005 Apr; 273(2):184-96. PubMed ID: 15731909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.